Delayed hypersensitivity reactions to corticostecoids applied to mucous membranes

British Journal of Dermatology

Volumn 135, Issue 2, 1996, Pages 310-313

  Bircher, A J ^a   Pelloni, F ^b   Langauer Messmer, S ^a   Muller D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMCINONIDE; ANTIHISTAMINIC AGENT; BENZALKONIUM CHLORIDE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; BUDESONIDE; CEFUROXIME; CETYLPYRIDINIUM SALT; CLOBETASOL PROPIONATE; CORTICOSTEROID; DESOXIMETASONE; DIFLUCORTOLONE VALERATE; FLUMETASONE PIVALATE; FLUNISOLIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; HALCINONIDE; HALOMETASONE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PETROLATUM; PREDNICARBATE; PREDNISOLONE; PREDNITOP; TIXOCORTOL PIVALATE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC RHINITIS; ANGIONEUROTIC EDEMA; APHTHOUS STOMATITIS; ARTICLE; ASTHMA; CASE REPORT; CONTACT ALLERGY; DELAYED HYPERSENSITIVITY; DRUG FORMULATION; ECZEMA; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; NOSE MUCOSA; NOSE OBSTRUCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; SNEEZING; TOPICAL DRUG ADMINISTRATION;

EID: 0030006342     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01169.x     Document Type: Article

References (32)

1. Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 1989; 121: 27-34.
2. Burden AD, Beck MH. Contact hypersensitivity to topical corticosteroids. Br J Dermatol 1992; 127: 497-500.
3. Lauerma AI. Contact hypersensitivity to glucocorticosteroids. Am J Contact Dermatitis 1992; 3: 112-32.
4. Dooms-Goossens A, Mooren M. Results of routine patch testing with corticosteroid series in 2073 patients. Contact Dermatitis 1992; 26: 182-91.
5. Dooms-Goossens A, Meinardi MMHM, Bos JD, Degreef H. Contact allergy to corticosteroids: the results of a two-centre study. Br J Dermatol 1994; 130: 42-7.
6. Bircher AJ, Thürlimann W, Hunziker T et al. Contact hypersensitivity to corticosteroids in routine patch test patients. Dermatology 1995; 191: 109-14.
7. Wilkinson SM, Hypersensitivity to topical corticosteroids. Clin Exp Dermatol 1994; 19: 1-11.
8. Dooms-Goossens A. Allergy to inhaled corticosteroids: a review. Am J Contact Dermatitis 1995; 6: 1-3.
9. Bircher AJ, Hirsbrunner P, Tschopp K, Wildermuth V. Allergic contact dermatitis from tixocortol pivalate in a nasal spray masquerading as infectious complication of sinusitis. ORL 1995; 57: 54-6.
10. Boujnah-Khouadja A, Brändle I, Reuter G, Foussereau J. Allergy to two new corticoid molecules. Contact Dermatitis 1984; 11: 83-7.
11. Camarasa JG, Malet A, Serra-Baldrich, Lluch M. Contact allergy to tixocortol pivalate. Contact Dermatitis 1988; 19: 147-8.
12. Bircher AJ. Short induction phase of contact allergy to tixocortol in a nasal spray. Contact Dermatitis 1990; 22: 237-8.
13. Meding B, Dahlberg E. Contact allergy to budesonide in a nasal spray. Contact Dermatitis 1986; 14: 253-4.
14. Jerez J, Rodríguez F, Garcés M et al. Allergic contact dermatitis from budesonide. Contact Dermatitis 1990; 22: 231-2.
15. Camboa PM, Jáuregui I, Antépara I. Contact dermatitis from budesonide in a nasal spray without cross-reactivity to amcinonide. Contact Dermatitis 1991; 24: 227-8.
16. Peris-Tortajada A, Giner A, Perez C et al. Contact allergy to topical budesonide. J Allergy Clin Immunol 1991; 87: 597-8.
17. Faria A, Marote J, De Freitas C. Contact allergy to budesonide in a nasal spray. Contact Dermatitis 1992; 27: 57.
18. Sastre J, Ibañez MD. Contact allergy to budesonide contained in a nasal spray. Allergy 1992; 47: 661-2.
19. Jorro G, Rochina A, Morales C et al. Contact allergy to topical budesonide in a nasal spray. Contact Dermatitis 1993; 28: 254.
20. Hürlimann AF, Schmid-Grendelmeier P, Elsner P, Wüthrich B. Allergische Kontaktdermatitis auf das Kortikosteroid Budesonid nach intranasaler Anwendung. Otorhinolaryngol Nova 1994; 4: 168-70.
21. Iglesias-Cardarso A, Diaz C, Laguna JJ, Hernandez-Weigand P. Allergic contact dermatomucositis to budesonide. J Allergy Clin Immunol 1994; 94: 559-60.
22. Callens A, Vaillant L, Machet L et al. Contact stomatitis from tixocortol pivalate. Contact Dermatitis 1993; 29: 161.
23. Garcia-Abujeta JL, Fernandez L, Maquiera E et al. Contact allergy to budesonide in an oral spray. Contact Dermatitis 1995; 32: 253.
24. Lauerma AI, Kiistala R, Mäkinen-Kiljunen S, Haathela T. Allergic skin reaction after inhalation of budesonide. Clin Exp Allergy 1993; 23: 232-3.
25. Holmes P, Cowen P. Spongiotic (eczematous type) dermatitis after inhaled budesonide. Aust NZ J Med 1992; 22: 511.
26. Fuchs Th, Uter W, Sprotte U. Generalisierte Urtikaria durch Budesonid- verzögerte, IgE-vermittelte Sofortreaktion? Allergologie 1991; 14: 234-8.
27. Lauerma AI, Räsänen L, Reunala T, Reitamo S. Langerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensitivity. Br J Dermatol 1990: 123: 699-705.
28. Yoshimi R, Takamura H, Takasaki K, Kumagami H. Immunohistologic study of the nasal mucosa with reference to Langerhans cells. Nippon Jibiinkoka Gakkai Kaiho 1993; 96: 1252-7.
29. Igarashi Y, Kaliner MA, Hausfeld JN et al. Quantification of resident inflammatory cells in the human nasal mucosa. J Allergy Clin Immunol 1993; 91: 1082-93.
30. Bircher AJ, Hampl K, Hirsbrunner P et al. Allergic contact dermatitis to ethyl chloride and sensitization to dichlorodifluoromethane (CFC 12). Contact Dermatitis 1994: 31: 41-4.
31. Bernstein IL. Medical hazards of aerosols. Parts I and II. Postgrad Med 1972; 52: 62-8. 73-7.
32. Malish DM. Possible allergic reactions to inert ingredient in Alupent metered dose inhaler, sorbitan sesquiolate. Immunol Allergy Pract 1985; 7: 467-9.